Norihiro Kaneko

Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer

Katsutoshi Ando, Fumiyuki Takahashi, Motoyasu Kato et al. · PLoS ONE · 2014 · 128 citations · Full text

Medicine, Immunology, Oncology +15

Possible Role for Tocilizumab, an Anti–Interleukin-6 Receptor Antibody, in Treating Cancer Cachexia

Katsutoshi Ando, Fumiyuki Takahashi, Shinji Motojima et al. · Journal of Clinical Oncology · 2012 · 124 citations · Full text

Medicine, Hematology, Oncology +13

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis

Tamao Nakashita, Katsutoshi Ando, Norihiro Kaneko et al. · BMJ Open · 2014 · 121 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Stopping<i>versus</i>continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)

Wendy C. Moore, Oliver Kornmann, Marc Humbert et al. · European Respiratory Journal · 2021 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection

Nobuhiro Asai, Shinji Motojima, Yoshihiro Ohkuni et al. · Journal of Infection and Chemotherapy · 2012 · 70 citations

Medicine, Clinical Sciences, Infectious Diseases +15